The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Eversheds Sutherland AG

SCHWANENGASSE 1, 3001 BERNE, SWITZERLAND
Tel:
Work +41 31 328 75 75
Fax:
Fax +41 31 328 75 76
Email:
Web:
www.eversheds-sutherland.ch

Peter Haas

Tel:
Work +41 31 328 75 75
Email:
Eversheds Sutherland

Work Department

Peter Haas is a founding partner of Eversheds Sutherland in Switzerland and was Managing Partner from September 2013 until January 2019. His practice areas are national and international litigation as well as employment and contract law. Peter has a particular expertise in insurance and liability matters. He is the head of the insurance team (including social insurance) at Eversheds Sutherland Switzerland. His prior experience includes several years as an in-house counsel in the claims department of one of the largest Swiss insurance companies as well as an associate attorney in a business law firm.

Peter studied Law at the University of Berne and was admitted to the bar in Switzerland in 1994. He holds an LL.M. in European law, private international law and arbitration from the University of Essex (UK).

Peter is a member of the executive board of the Bar Association of the Canton of Berne and a member of the Swiss Bar Association. He is a member of the IBA’s insurance committee, its negligence and damages as well as its litigation committee. He is also a member of the Swiss Society of Civil Liability and Insurance Law and its committee AIDA Swiss Chapter and the British-Swiss Chamber of Commerce (BSCC).

Position

Partner

Languages

German, English, French


Switzerland

Dispute resolution: litigation

Within: Dispute resolution: litigation

Eversheds Sutherland AG's partners are recommended for being 'time-conscious and responsive, as well as good listeners'. With qualifications in both Swiss and English law, the litigators are experienced in banking, telecoms and IT, commodities, engineering, real estate and construction, as well as white-collar criminal law matters. Global head of dispute resolution, the 'experienced and creative' Claudius Triebold, is one of the seven key partners. Monika McQuillen, Peter Haas and Barbara Klett are also singled out by clients. James Hargrove left for Orrick, Herrington & Sutcliffe LLP in February 2018.

[back to top]


Back to index

Legal Developments in Switzerland

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to
  • Bär & Karrer Continues to Grow Finance and Sports Practice with Two New Partners

    Bär & Karrer is pleased to announce that it further strengthens its Financing and Sports practices with new partners Lukas Roesler and Dr. Jan Kleiner, both of whom have worked with the firm previously.
  • Bär & Karrer Advises Novartis and Alcon on the Spin-off of Alcon

    Today, Novartis AG completed the spin-off of the Alcon eye care devices business, and Alcon Inc. debuted as independent publicly traded company. The Alcon shares were successfully listed on the SIX Swiss Exchange Ltd. and the New York Stock Exchange. They are also included in the Swiss Market Index (SMI), which comprises the 20 largest Swiss listed stocks.
  • Bär & Karrer Advises Primeo Energie and CSA Energie-Infrastructure Schweiz in Aquisition from ElĂ©t

    Primeo Energie, EOS Holding SA (EOS) and Électricité de France (EDF) have entered into a share purchase agreement relating to the purchase by Primeo Energie and EOS of the 25% interest held by EDF in Alpiq Holding SA. The purchase by Primeo Eergie and EOS will be financed through mandatory exchangeable loan agreements made by CSA Energie-Infrastruktur Schweiz (CSA) as lender, the biggest investment pool for Swiss energy infrastructure with 135 Swiss pension funds acting as investors. At maturity the mandatory exchangeable loan agreements will be converted into shares in Alpiq. Primeo Energie and EOS thereby pave the way for a Swiss shareholder structure of Alpiq.
  • Bär & Karrer Awarded Most Innovative Swiss Law Firm of the Year at the IFLR Europe Awards

    Bär & Karrer was awarded „Most innovative law firm of the year - Switzerland", the national award for Switzerland given in the IFLR European Awards. The most innovative law firm of the year award recognizes Bär & Karrer as the Swiss law firm with the best track record in 2018 giving advice on the most innovative cross-border deals covering all award practice areas. It is already the third prize of this kind in period of six years awarded to Bär & Karrer.
  • Bär & Karrer Advises DSV on Public Exchange Offer for Panalpina

    On 1 April 2019, DSV A/S, Hedehusene, Denmark and Panalpina Welttransport (Holding) AG, Zurich, Switzerland, have entered into an agreement on the terms and conditions of a combination by way of a public exchange offer by DSV for all publicly held registered shares of Panalpina for approximately CHF 4.6 billion. The board of directors of Panalpina has resolved to support the public exchange offer by DSV and to recommend the acceptance of DSV's public exchange offer to its shareholders.
  • Bär & Karrer Advises Lonza on the Entering into a Strategic Joint Venture with Chr. Hansen for Deve

    On 2 April 2019, Lonza, a leading pharma contract manufacturing company, and Chr. Hansen, a leading global bioscience company, announced that they have signed an agreement to establish a 50/50 joint venture to pioneer the live biotherapeutic products (LBPs) industry and position themselves as the leading contract development and manufacturing partner (CDMO) for biotech and pharma customers. The joint venture brings together best-in-class, complementary capabilities and will be the first CDMO globally to provide a full supply chain that offers manufacturing of bacteria strains for therapeutic use. The joint venture will be a 50/50 controlled legal entity that will operate from its headquarters in Basel (CH) and have production facilities in Denmark and Switzerland. A phased investment of approximately EUR 90 million will be deployed over three years to build cGMP-compliant pharma production capabilities. The joint venture will upgrade existing facilities in Hørsholm (DK) and equip new facilities in Basel (CH) to serve pre-clinical to phase II projects. Further facilities for phase III and commercial manufacturing will be developed as the pipeline matures. The joint venture is expected to be largely self-funding after the production set-up has been established.
  • Bär & Karrer Advises Computacenter in the Acquisition of PathWorks

    Computacenter Group, a leading European IT service provider listed on the London Stock Exchange, acquired PathWorks, a well-established hardware reseller in the Swiss market.
  • Bär & Karrer Advises Addtech in the Acquisition of a Majority in Omni Ray

    Addtech Group, a leading Swedish publicly listed technology trading group, acquired a majority stake in Omni Ray AG, a well-established Swiss trading company and service provider for automation solutions, mainly focused on industrial applications, infrastructure, transportation and medical industry. By this transaction, Addtech aims at strengthening its position in the European automation market.
  • Bär & Karrer Partner Paolo Bottini Wins the Client Choice Award 2019 by Lexology

    Bär & Karrer is pleased to announce that partner Paolo Bottini has been recognized by Lexology and the International Law Office (ILO) as the Client Choice Winner 2019 in the Corporate Tax category in Switzerland.
  • Bär & Karrer Advises CEVA Logistics in Connection with the Strengthening of the Strategic Partnersh

    On 11 October 2018, the board of directors of CEVA Logistics AG announced that the Danish transport and logistic company DSV submitted a non-binding letter of interest with an indicative offer price of CHF 27.75 per CEVA share and that the board of directors of CEVA came to the conclusion that the offer was not in the best interest of the company and its shareholders. This was in particular because at that point in time, CEVA was already in discussions regarding an intensified cooperation with its main shareholder CMA CGM S.A., which shall exploit the full potential of CEVA.